Registry of Lobbyists
| Organization: | Innovative Medicines Canada/Médicaments novateurs Canada |
| Associated registration: | 957857-371-115 |
| Communication date: | 2024-07-18 |
| Posted date: | 2024-08-14 |
| Designated Public Office Holders who participated in the communication: |
Jade Mallette,
Director of Parliamentary Affairs, office of the Minister of Health
Health Canada (HC) Mark Holland, Minister of Health Health Canada (HC) |
| Subject Matter of the communication: | Consumer Issues, Federal-Provincial Relations, Foreign Affairs, Health, Industry, Infrastructure, Intellectual Property, International Trade, Research and Development, Science and Technology, Small Business, Taxation and Finance |
| Responsible Officer who filed this communication report: | Bettina Hamelin |
| As the most senior paid officer, the person named above is responsible for certifying the communication report for the corporation or organization (Registrant). This person may or may not have participated in the reported communication. The Lobbyists Registration Regulations do not require that the names of in-house lobbyists (i.e. employees of corporations or organizations) who actually participated in the communication be disclosed. | |